Welcome To the Stock Synergy, Momentum & Breakout HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Klaus you aske about gnbt before

it takes alot of money for research and development of product. This one has been mismanaged but so far the new managment is seemingly trying to change. If news comes out of fda approval of oralynn that might do it. The rs has not been acted on which makes me think they want the sp up beforehand. Anyhow ouch is right...

Share
New Message
Please login to post a reply